Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

SGMOSGMO
17 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in SANGAMO THERAPEUTICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of SGMO (SANGAMO THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$410,000

Total Shares Change

-99,010

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.14
0
2026-Q1
Increased
2.1M
+95.1%
$506,2400.0%$0.39
38
2025-Q4
Increased
1.1M
+24.1%
$441,3000.0%$0.43
29
2025-Q3
Unchanged
846,533
0.0%
$570,0550.0%$0.70
0
2025-Q2
Decreased
846,533
-34.8%
$458,2280.0%$0.54
0
2025-Q1
Increased
1.3M
+74.8%
$851,0870.0%$0.82
37
2024-Q4
Decreased
742,462
-49.5%
$757,3110.0%$2.34
0
2024-Q3
Decreased
1.5M
-50.1%
$1.3M0.0%$0.87
0
2024-Q2
Increased
3M
+1437.4%
$1.1M0.0%$0.36
41
2024-Q1
Decreased
191,949
-81.0%
$128,6440.0%$0.67
0
2023-Q4
Increased
1M
+149.7%
$547,6800.0%$0.54
39
2023-Q3
Increased
403,782
+94.1%
$242,1880.0%$0.60
37
2023-Q2
Decreased
208,048
-60.1%
$270,4620.0%$1.25
0
2023-Q1
Increased
521,991
+344.2%
$918,7040.0%$1.70
40
2022-Q4
Decreased
117,524
-9.4%
$369,0260.0%$3.14
0
2022-Q3
Increased
129,789
+31.1%
$636,0000.0%$4.87
31
2022-Q2
New
99,010
-
$410,0000.0%$4.14
33

Other major holders of SGMO: BNP PARIBAS FINANCIAL MARKETS, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used